Navigation Links
Surgistat Electrosurgical Generator

ProductsSurgistat Electrosurgical Generator
Company Valleylab
Item Surgistat Electrosurgical Generator
Features Easy and quick to set up; compact and light, saves time with automatic access to previously used power settings and modes, provides precise surgical effect with power control dials. Performs most common office-based electrosurgical procedures. Provides ability to change power settings while activating the generator. Includes both monopolar and bipolar outputs. Accepts preferred accessories standard 3-pin pencil, most standard footswitching devices (with adapter), and standard Valleylab monopolar footswitch (optional) - standard 2-pin bipolar footswitching devices. Increased patient safety with a return electrode contact quality monitoring system (RECQMS). The RECQMS system continually monitors patient impedance levels and deactivates the generator if a fault in the patient/return electrode contact is detected.
Description The Valleylab Surgistat II generator provides exceptional performance, reliability, and safety benefits in a compact, easy to use unit.
Info Valleylab
Customer Service: (800) 255-8522
Web site: http://www.valleylab.com/

Related medicine products :

1. Surgistat II Electrosurgical Generator.
2. Force EZ Electrosurgical Generator
3. Force FX Electrosurgical Generator
4. IDS-300 Electrosurgical Generator
5. IDS-200 Electrosurgical Generator
6. Finesse Electrosurgical Generator (100-120 VAC)
7. Finesse Electrosurgical Generator (200-240 VAC)
8. Finesse II Electrosurgical Generator (100-120 VAC)
9. Finesse II Electrosurgical Generator (200-240 VAC)
10. PenAdapt - Electrosurgical Pencil Adapter For The Collection Of Smoke Plume
11. Mega Power Electrosurgical Generator
Breaking Medicine Technology:Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Asthmatx Receives FDA Advisory Panel Recommendation for Approvable with Conditions for Bronchial Thermoplasty with the Alair 28R 29 System for Severe 5807 1Asthmatx Receives FDA Advisory Panel Recommendation for Approvable with Conditions for Bronchial Thermoplasty with the Alair 28R 29 System for Severe 5807 2Asthmatx Receives FDA Advisory Panel Recommendation for Approvable with Conditions for Bronchial Thermoplasty with the Alair 28R 29 System for Severe 5807 3Experience the Future of Assistive Technology at Abilities Expo on November 6 8 2009 60288 1Experience the Future of Assistive Technology at Abilities Expo on November 6 8 2009 60288 2Nuvo announces 2009 third quarter financial results 60283 1Nuvo announces 2009 third quarter financial results 60283 2Nuvo announces 2009 third quarter financial results 60283 3Nuvo announces 2009 third quarter financial results 60283 4Nuvo announces 2009 third quarter financial results 60283 5Nuvo announces 2009 third quarter financial results 60283 6Nuvo announces 2009 third quarter financial results 60283 7Nuvo announces 2009 third quarter financial results 60283 8Nuvo announces 2009 third quarter financial results 60283 9Nuvo announces 2009 third quarter financial results 60283 10Nuvo announces 2009 third quarter financial results 60283 11Nuvo announces 2009 third quarter financial results 60283 12